Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12341
Abstract: EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation evaluated use of nonvitamin K antagonist oral anticoagulant edoxaban vs enoxaparin‐warfarin in patients with nonvalvular atrial fibrillation undergoing electrical cardioversion. read more here.
Keywords: atrial fibrillation; edoxaban versus; warfarin subjects; versus warfarin ... See more keywords
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-019-01594-9
Abstract: Background In ENSURE-AF study, edoxaban had similar efficacy and safety profile versus enoxaparin–warfarin (enox–warf) in patients undergoing electrical cardioversion of non-valvular atrial fibrillation. Objectives To evaluate the efficacy and safety of edoxaban versus enox–warf in… read more here.
Keywords: enox warf; edoxaban versus; safety; efficacy ... See more keywords
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-020-02199-0
Abstract: There is limited data evaluating clinical outcomes of rivaroxaban versus warfarin in obese patients with venous thromboembolism (VTE). Our objective was to evaluate the effectiveness and safety of rivaroxaban versus warfarin in obese VTE patients.… read more here.
Keywords: vte; rivaroxaban versus; versus warfarin; warfarin obese ... See more keywords
Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents
Sign Up to like & getrecommendations! Published in 2020 at "Journal of General Internal Medicine"
DOI: 10.1007/s11606-020-05777-3
Abstract: Background Research comparing direct-acting oral anticoagulants (DOACs) to warfarin has excluded nursing home residents, a vulnerable and high-risk population. Objective To compare the safety and effectiveness of DOACs versus warfarin. Design New-user cohort study (2011–2016).… read more here.
Keywords: direct acting; home residents; nursing home; versus warfarin ... See more keywords
Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Lung Transplant Recipients
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Heart and Lung Transplantation"
DOI: 10.1016/j.healun.2021.01.1054
Abstract: Purpose Lung transplant recipients (LTRs) are at an increased risk for venous thromboembolism (VTE) after transplant, necessitating the use of anticoagulation. Guidelines recommend direct oral anticoagulants (DOACs) over warfarin for most patients and indications; however,… read more here.
Keywords: vte; transplant recipients; lung; transplant ... See more keywords
Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.08.2137
Abstract: We would like to thank both Dr. Aloia and Drs. Ye and colleagues for their comments about our study [(1)][1]. A concern about our study is the observational nature, and therefore, the results should be… read more here.
Keywords: preventing myocardial; myocardial infarction; versus warfarin; doacs versus ... See more keywords
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state.
Sign Up to like & getrecommendations! Published in 2018 at "Thrombosis research"
DOI: 10.1016/j.thromres.2018.01.046
Abstract: INTRODUCTION Screening for primary hypercoagulable states (PHSs) in venous thromboembolism (VTE) patients was not mandated in the EINSTEIN trials; and therefore, few patients with a known PHS were available for analysis. We sought to assess… read more here.
Keywords: rivaroxaban versus; effectiveness safety; patients known; rivaroxaban ... See more keywords
NOACS VERSUS WARFARIN USE IN THE MANAGEMENT OF ATRIAL FIBRILLATION PATIENTS
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)33734-8
Abstract: Background: Novel oral anti-coagulation therapies (NOAC) have now become the standard of care treatment among patients at risk of stroke with non-valvular atrial fibrillation (AF) in the US. NOAC use has significantly increased since the… read more here.
Keywords: atrial fibrillation; fibrillation; noacs versus; versus warfarin ... See more keywords
EFFECTIVENESS AND SAFETY OF APIXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ENROLLED IN MEDICARE AND VETERAN AFFAIRS
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(21)02950-8
Abstract: Methods: This retrospective study used body weight data ≥100kg or body mass index (BMI) ≥30 to identify NVAF patients with obesity among dually enrolled Veterans Affairs (VA) and fee-for-service (FFS) Medicare patients. It evaluated risk… read more here.
Keywords: safety apixaban; obese patients; effectiveness safety; apixaban versus ... See more keywords
Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial.
Sign Up to like & getrecommendations! Published in 2020 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0040-1716540
Abstract: BACKGROUND The effects of anticoagulants at extremes of body weight (BW) are not well described. The aim of this study was to analyze the pharmacokinetics/pharmacodynamics and clinical outcomes in patients randomized to warfarin, higher dose… read more here.
Keywords: trend; versus warfarin; lbw patients; engage timi ... See more keywords
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0041-1740254
Abstract: There has been limited evidence reported about the outcomes of oral anticoagulants among patients with venous thromboembolism (VTE) and chronic kidney disease (CKD), especially those with stage V/end-stage renal disease (ESRD). This retrospective cohort analysis… read more here.
Keywords: recurrent vte; versus warfarin; apixaban versus; disease ... See more keywords